Response to: 'MBDA: what is it good for?' by Yazici et al

Advances in the treatment of systemic lupus erythematosus: Biologicals, small-molecular agents, and cell-depleting therapies coming to the clinic.

Journal of internal medicine·2026

Lupus trials and tribulations: are outcome measures the problem?

EULAR rheumatology open·2026

Belimumab outperforms placebo for attainment of modified DORIS remission and LLDAS without the glucocorticoid component: a post hoc analysis of five phase III SLE trials.

RMD open·2026

The EULAR Research Center-5 years young and going strong.

EULAR rheumatology open·2026

Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritis.

Journal of internal medicine·2026

Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trial.

The Lancet. Rheumatology·2026

Automated detection of active and structural MRI lesions in the sacroiliac joints in axial spondyloarthritis: training and validation across 3 phase III clinical trial datasets.

Annals of the rheumatic diseases·2026

Performance of a triage approach for identification of patients with inflammatory rheumatic and musculoskeletal diseases among rheumatology referrals.

Annals of the rheumatic diseases·2026

Validation of systemic Juvenile Arthritis Disease Activity Score 10 in adults with Still's disease.

Annals of the rheumatic diseases·2026

SDH inhibition quenches rheumatoid arthritis flare-associated IL-1β+IFN-γ+ macrophages via NF-κB/STAT4.

Annals of the rheumatic diseases·2026

Difficult-to-manage and treatment-refractory psoriatic arthritis in patients treated with biological and targeted synthetic DMARDs: prevalence and characteristics in 5 Nordic registries.

Annals of the rheumatic diseases·2026

Immune reset after deep B-lineage depletion: remission is not reprogramming.

Annals of the rheumatic diseases·2026

Morus alba leaf tea consumption reduces hyperlipidaemia, adipocyte hypertrophy and inflammation in HFD-induced obese mice.

Journal of traditional and complementary medicine·2026

A Flavonoid Malonyltransferase MnMaT1, Directly Regulated by MnATHB51, Leads to the Biosynthesis of Acylated Flavonol Glucosides in Morus notabilis.

Journal of agricultural and food chemistry·2026

Mucuna pruriens var. pruriens Ethanolic Seed Extract Enhances Erectile Function-Related Mechanisms: Integrated In Vitro and In Vivo Evidence.

Biology·2026

Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

Leukemia·2026

Mavacamten monotherapy in obstructive hypertrophic cardiomyopathy: an integrated analysis of phase 3 clinical trials.

American heart journal·2026

Aqueous extracts of Moringa oleifera and Carica papaya moderately reduce gastrointestinal helminth burden in sheep under field conditions in Ghana.

Frontiers in veterinary science·2026

Related Experiment Videos

Response to: 'MBDA: what is it good for?' by Yazici et al

Related Concept Videos

Advances in the treatment of systemic lupus erythematosus: Biologicals, small-molecular agents, and cell-depleting therapies coming to the clinic.

Lupus trials and tribulations: are outcome measures the problem?

Belimumab outperforms placebo for attainment of modified DORIS remission and LLDAS without the glucocorticoid component: a post hoc analysis of five phase III SLE trials.

The EULAR Research Center-5 years young and going strong.

Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritis.

Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trial.

Automated detection of active and structural MRI lesions in the sacroiliac joints in axial spondyloarthritis: training and validation across 3 phase III clinical trial datasets.

Performance of a triage approach for identification of patients with inflammatory rheumatic and musculoskeletal diseases among rheumatology referrals.

Validation of systemic Juvenile Arthritis Disease Activity Score 10 in adults with Still's disease.

SDH inhibition quenches rheumatoid arthritis flare-associated IL-1β+IFN-γ+ macrophages via NF-κB/STAT4.

Difficult-to-manage and treatment-refractory psoriatic arthritis in patients treated with biological and targeted synthetic DMARDs: prevalence and characteristics in 5 Nordic registries.

Immune reset after deep B-lineage depletion: remission is not reprogramming.

Morus alba leaf tea consumption reduces hyperlipidaemia, adipocyte hypertrophy and inflammation in HFD-induced obese mice.

A Flavonoid Malonyltransferase MnMaT1, Directly Regulated by MnATHB51, Leads to the Biosynthesis of Acylated Flavonol Glucosides in Morus notabilis.

Mucuna pruriens var. pruriens Ethanolic Seed Extract Enhances Erectile Function-Related Mechanisms: Integrated In Vitro and In Vivo Evidence.

Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

Mavacamten monotherapy in obstructive hypertrophic cardiomyopathy: an integrated analysis of phase 3 clinical trials.

Aqueous extracts of Moringa oleifera and Carica papaya moderately reduce gastrointestinal helminth burden in sheep under field conditions in Ghana.

Related Experiment Videos

Response to: 'MBDA: what is it good for?' by Yazici et al

Related Concept Videos

Related Articles